MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2025 International Congress

    Unraveling the Genetic Architecture of Progressive Supranuclear Palsy in East Asians

    P. Chen, R. Lin, N. Lee, J. Hsu, C. Tai, R. Wu, H. Chiang, Y. Wu, C. Lu, H. Chang, T. Lee, Y. Chang, C. Lin (Taipei, Taiwan)

    Objective: We aim to elucidate the genetic architecture of progressive supranuclear palsy (PSP) in East Asians through whole-exome sequencing in a multi-center study in Taiwan.…
  • 2025 International Congress

    Parkinsonism in Uzbekistan: Clinical and Demographic Insights from 2024

    Y. Nishonova, B. Mukhammedaminov, L. Kenjaeva, N. Aripova (Tashkent, Uzbekistan)

    Objective: We retrospectively analyzed the medical records of all parkinsonism patients admitted to our clinic in 2024, examining neurological, psychiatric, radiological, and demographic characteristics of…
  • 2025 International Congress

    Gait Variability is Associated with Executive Function in Progressive Supranuclear Palsy

    A. D'Souza, C. Sotirakis, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: This study aims to investigate the relationship between executive function and gait in PSP using clinical assessments and objective gait analysis with wearable sensors.…
  • 2025 International Congress

    Identification of Genetic Variants in Progressive Supranuclear Palsy in China

    Y. Kang, W. Luo (Hangzhou, China)

    Objective: To delineate the genetic landscape of progressive supranuclear palsy (PSP) in Chinese patients.Progressive supranuclear palsy is a neurodegenerative disorder primarily considered sporadic, with MAPT…
  • 2025 International Congress

    Changes in Inhibitory Control Differentiate Progressive Supranuclear Palsy from Early Parkinson’s Disease

    B. Couto, F. Castano, J. Carrillo, M. Roca, A. Chade, O. Gershanik, G. Gomez-Arevalo (Buenos Aires, Argentina)

    Objective: To describe distinct type of errors and frequency of perseverative errors in executive, memory, language, and attentional tasks in PSP and PD. Background: Progressive…
  • 2025 International Congress

    The Sedentary Index (SI) for Daily Life Activity Monitoring in Progressive Supranuclear Palsy (PSP)

    M. Dale, C. Silva-Batista, A. Ragothaman, Z. Nhem, A. Lawston, G. Harker, D. Maxwell, C. Speirs, D. Loudon, M. Mancini (Portland, USA)

    Objective: To confirm the feasibility of daily life physical activity monitoring in PSP using a single activPAL sensor, and to examine preliminary associations between overall…
  • 2025 International Congress

    Clinical Features Suggestive of Alpha-Synucleinopathy in Progressive Supranuclear Palsy

    C. Painous, A. Martínez-Reyes, J. Santamaria, M. Fernández, A. Cámara, Y. Compta (Barcelona, Spain)

    Objective: To compare the presence of symptoms suggestive of synucleinopathy between PSP-parkinsonism (PSP-P), Parkinson's disease (PD) and PSP-Richardson syndrome (PSP-RS). Background: Clinical signs with high…
  • 2025 International Congress

    A Case of Mixed Presentation of 4R Tauopathies

    S. Ghourchian, A. Kay (Brooklyn, USA)

    Objective: To describe the diagnostic challenges, and management of a patient with overlapping features of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP) Background: CBS…
  • 2025 International Congress

    Plasma tau-species-containing neuron-derived extracellular vesicles as potential biomarkers for progressive supranuclear palsy

    YC. Zheng, HH. Cai, WY. Kou, ZW. Yu, T. Feng (Beijing, China)

    Objective: This study aimed to develop and validate novel plasma PSP biomarkers based on tau-species-containing neuron-derived extracellular vesicles (NDEVs) in two independent cohorts (discovery and…
  • 2025 International Congress

    Clinical Deficits, Quality of Life and Caregiver Burden across PSP Phenotypes

    A. Cámara, I. Zaro, C. Painous, Y. Compta (Barcelona, Spain)

    Objective: To assess clinical deficits, quality of life and caregiver burden across progressive supranuclear palsy (PSP) phenotypes considering also other variables such as age, sex…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley